This inventor holds 1 USPTO granted patent and 4 published patent applications and 2 EPO patents. Top assignee: Bruker Cellular Analysic, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Amanda L. Goodsell: Innovator in Microfluidic Technology
Introduction
Amanda L. Goodsell is a prominent inventor based in Emeryville, California. She has made significant contributions to the field of microfluidics, particularly in the assay of biological cells. Her innovative work focuses on the automated detection and characterization of micro-objects, which has important implications for biomedical research.
Latest Patents
Amanda holds a patent for "Methods for assaying biological cells in a microfluidic device." This patent outlines methods for the assay of secreted biomolecules, specifically those produced by immunological cells such as T cells. The biomolecules being assayed include cytokines and growth factors. Additionally, her patent provides methods for assessing the cytotoxicity of one cell type with respect to another target cell. The invention also includes kits and computer-readable media that facilitate automated detection of secreted biomolecules and cytotoxicity in microfluidic devices.
Career Highlights
Throughout her career, Amanda has worked with notable companies, including Bruker Cellular Analysis, Inc. Her experience in these organizations has allowed her to refine her skills and contribute to advancements in cellular analysis technologies.
Collaborations
Amanda has collaborated with talented individuals in her field, including Yelena Bronevetsky and Annamaria Mocciaro. These collaborations have further enhanced her research and development efforts.
Conclusion
Amanda L. Goodsell is a trailblazer in the realm of microfluidic technology, with a focus on biological assays. Her innovative patent and career achievements underscore her impact on the field. Her work continues to pave the way for advancements in biomedical research and applications.